Morgan Stanley’s Gamida Cell Ltd. Ordinary Shares GMDA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-1,292
| Closed | -$47 | – | 8073 |
|
|
2024
Q1 | $47 | Sell |
1,292
-394,374
| -100% | -$135K | ﹤0.01% | 7507 |
|
|
2023
Q4 | $163K | Buy |
395,666
+245,171
| +163% | +$138K | ﹤0.01% | 6021 |
|
|
2023
Q3 | $155K | Buy |
150,495
+4,762
| +3% | +$6.08K | ﹤0.01% | 5697 |
|
|
2023
Q2 | $281K | Buy |
145,733
+43,738
| +43% | +$75.3K | ﹤0.01% | 5490 |
|
|
2023
Q1 | $82.6K | Sell |
101,995
-24,113
| -19% | -$35.2K | ﹤0.01% | 6089 |
|
|
2022
Q4 | $163K | Sell |
126,108
-15,403
| -11% | -$24.4K | ﹤0.01% | 5752 |
|
|
2022
Q3 | $225K | Buy |
141,511
+15,754
| +13% | +$35.9K | ﹤0.01% | 5679 |
|
|
2022
Q2 | $223K | Buy |
125,757
+1,331
| +1% | +$3.38K | ﹤0.01% | 5843 |
|
|
2022
Q1 | $517K | Buy |
124,426
+48,824
| +65% | +$164K | ﹤0.01% | 5387 |
|
|
2021
Q4 | $192K | Buy |
75,602
+10,238
| +16% | +$33.7K | ﹤0.01% | 6096 |
|
|
2021
Q3 | $256K | Sell |
65,364
-7,222
| -10% | -$36.1K | ﹤0.01% | 5870 |
|
|
2021
Q2 | $465K | Buy |
72,586
+43,794
| +152% | +$302K | ﹤0.01% | 5567 |
|
|
2021
Q1 | $233K | Buy |
28,792
+800
| +3% | +$7.34K | ﹤0.01% | 5575 |
|
|
2020
Q4 | $235K | Buy |
27,992
+3,037
| +12% | +$20.6K | ﹤0.01% | 5513 |
|
|
2020
Q3 | $104K | Sell |
24,955
-895
| -3% | -$3.81K | ﹤0.01% | 5421 |
|
|
2020
Q2 | $118K | Buy |
25,850
+25,847
| +861,567% | +$119K | ﹤0.01% | 5327 |
|
|
2020
Q1 | $0 | Buy |
+3
| New | +$13 | ﹤0.01% | 6758 |
|
Other funds holding GMDA
Morgan Stanley's GMDA Position: Q2 2024 in Review
Morgan Stanley sold out of Gamida Cell Ltd. Ordinary Shares (GMDA) in Q2 2024, closing a stake of 1,292 shares — an estimated $47 sold.
Morgan Stanley first reported a position in GMDA in Q1 2020 and held it in 17 quarters. The position peaked at $517K in Q1 2022. 2 funds tracked by Wall St. Rank hold GMDA as of Q2 2024.
- Morgan Stanley reported no remaining Gamida Cell Ltd. Ordinary Shares position as of Q2 2024 after selling out during the quarter.
- Morgan Stanley sold 1,292 Gamida Cell Ltd. Ordinary Shares shares in Q2 2024, an estimated $47.
- Morgan Stanley first reported a position in Gamida Cell Ltd. Ordinary Shares in Q1 2020 and held it in 17 quarters.
- Morgan Stanley's Gamida Cell Ltd. Ordinary Shares position peaked at $517K in Q1 2022.
- 2 funds tracked by Wall St. Rank held Gamida Cell Ltd. Ordinary Shares as of Q2 2024.
Based on Morgan Stanley's 13F filing for Q2 2024, filed 14 Aug 2024.